NCT01245790 A Study of Fostamatinib in Subjects With Impaired Kidney Function Status COMPLETED Phase PHASE1
NCT01244711 Open-Label Pilot Study to Examine the Value of Substituting Quetiapine for Benzodiazepines Status TERMINATED Phase PHASE4
NCT01244646 Hypoglycemia- and Weight-related Quality of Life in Patients With Diabetes Mellitus Type 2 on Sulfonylurea Derivatives. Status TERMINATED Phase N/A
NCT01243255 Polish Survey on the Efficacy of the Hypercholesterolemia Treatment Status COMPLETED Phase N/A
NCT01242605 ABC-04 a Study of Cisplatin, Gemcitabine and Selumetinib in Patients With Advanced Biliary Tract Cancer Status COMPLETED Phase PHASE1
NCT01242514 Evaluation of Long-term Safety and Effectiveness of Fostamatinib in the Treatment of Rheumatoid Arthritis (RA) Status TERMINATED Phase PHASE3
NCT01240967 To Compare the Pharmacokinetics of a Single Oral Dose of TC-5214 in Subjects With Renal Impairment and With Subjects With Normal Renal Function Status COMPLETED Phase PHASE1
NCT01240148 Determine the Effect of AZD3161,Injected Intradermally, on Quantitative Sensory Testing Variables in Normal and Ultraviolet-C (UVC) Exposed Skin in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01239771 A Study to Assess Safety and Tolerability as Well as Absorption and Excretion of TC-5214 in Medically Stable Elderly Subjects Status COMPLETED Phase PHASE1
NCT01239589 European Study to Describe Hospital Stay in Patients Admitted for Acute Bipolar Manic Episodes Status COMPLETED Phase N/A
NCT01238809 Gastroprotective Agent Utilization and Compliance in Patients > 60 Years Taking Low-dose Aspirin in France Status WITHDRAWN Phase N/A
NCT01235741 A Study To Examine The Efficacy And Safety Of Pramlintide+Metreleptin In Obese Subjects Status TERMINATED Phase PHASE2
NCT01233830 Study to Investigate Safety, Tolerability and Pharmacokinetics of AZD2423 Multiple Doses in Healthy Japanese Volunteers Status COMPLETED Phase PHASE1
NCT01233232 A 4 Week Study to Investigate the Safety and Tolerability of AZD5069 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE2
NCT01232335 Symbicort Turbuhaler 30/60 Specific Clinical Experience Investigation Status COMPLETED Phase N/A
NCT01232322 Pulmicort Respules 0.25/0.5 Specific Clinical Experience Investigation Status COMPLETED Phase N/A